TScan Therapeutics, Inc. (TCRX)
1.04
+0.02
(+2.46%)
USD |
NASDAQ |
Dec 10, 16:00
1.04
0.00 (0.00%)
After-Hours: 19:28
TScan Therapeutics Market Cap: 59.02M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 53.41B |
| Geron Corp. | 826.67M |
| Novavax, Inc. | 1.094B |
| XOMA Royalty Corp. | 425.61M |
| SELLAS Life Sciences Group, Inc. | 279.90M |
Market Cap Related Metrics
| PS Ratio | 15.74 |
| Price to Book Value | 0.4097 |
| Price | 1.04 |
| Earnings Yield | -107.6% |